Best Practices in ART Following Recent Drug Approvals
Eric S. Daar, MD, and Joel E. Gallant, MD, MPH 
How do TAF- and TDF-based regimens compare?
Download SlidesNovel Strategies and Agents for HIV Management
Daniel R. Kuritzkes, MD, and Paul E. Sax, MD 
Are you prepared to use long-acting ART, dual-therapy regimens, and investigational agents upon approval?
Download SlidesUpdate on the Management of ART in HCV/HIV Coinfection
Susanna Naggie, MD, MHS, and David L. Wyles, MD 
Are you keeping up with the rapid pace of development in HCV therapy? 
Download SlidesUpdating Your Practice Based on New Guideline Recommendations
Eric S. Daar, MD, and Paul E. Sax, MD 
Have you modified your practice to align with the updated DHHS ART guidelines? 
Download SlidesManagement of Older Patients
David A. Wohl, MD 
Are you able to manage key comorbidities and pharmacotherapy concerns in the aging patient population?
Download SlidesManagement of HIV in Women
Sally Hodder, MD, and Kathleen E. Squires, MD 
Do you know how newer ART regimens perform in women?
Download SlidesART for HIV Prevention: Current Best Practices and Emerging Strategies
Jared M. Baeten, MD, PhD, and Myron S. Cohen, MD 
Options for HIV prevention are expanding. Will you be ready to counsel your patients? 
Download Slides